ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Congress Ignores construction Fund Reprogramming

February 18, 1977

NCI Advisory Group Meetings for September

August 29, 1975

AACR Honors Scientists: Opens Web Sites

May 10, 1996

Funding opportunities listed.

November 19, 2004

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

Clearinghouse Funds Two Carcinogens And A Threat To Humans

March 17, 1978